Treatment and followup outcomes of gynecological cancer patients treated with radiation therapy during lockdown phase of COVID pandemic

Not yet recruiting

• Conditions: Coronavirus as the cause of diseases classified elsewhere, (2) ICD-10 Condition: C51-C58||Malignant neoplasms of female genital organs,

• Registration Number: CTRI/2020/10/028571
• Lead Sponsor: Tata Memorial Centre

Brief Summary

This is an observational retrospective cohort study. The primary aim of the study is to audit cancer care of Gynaecological patients of all age groups who were treated, referred outside, and/or on follow-up from 01.03.2020 to 31.07.2020 (or extended COVID-19 pandemic lockdown period as deemed necessary by government). The study will recruit a total of 1500 patients.

Detailed Description

Not available

Study Timeline

• Last Update Posted: 2020-10-22
• Study Start: 2020-10-30

Recruitment & Eligibility

• Status: Not Yet Recruiting
• Sex: Female
• Target Recruitment: 1500

Inclusion Criteria

• Patients treated in Gynecology unit of radiation therapy in TMH, referred out, and/or followed up from 01.03.2020 to 31.07.2020 2.
• All age groups will be included in the study.

Exclusion Criteria

Not provided

Study & Design

• Study Type: Observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Audit of treatment characteristics of patients treated during COVID- 19 lockdown period.	01.03.2020 to 31.07.2020

Secondary Outcome Measures

Name	Time	Method
To report on common patient symptoms during telephonic follow up consultation	During COVID- 19 lockdown period.
Compliance of patients	During COVID- 19 lockdown period.
Acute complications and outcomes of treatment of patients treated	3 years
To report on long term cancer specific outcomes of patients treated	3 years

Trial Locations

Locations (1)

Tata Memorial Centre and Advance Centre for Treatment, Research and Education in Cancer; 🇮🇳 Mumbai, MAHARASHTRA, India

Tata Memorial Centre and Advance Centre for Treatment, Research and Education in Cancer

🇮🇳Mumbai, MAHARASHTRA, India

Dr Supriya Chopra

Principal investigator

9930958309

supriyasastri@gmail.com